Clinical Trial Update: Clinical Endpoint Trial Investigating Once Daily and Bronchodilator Dosing [Phase 2]

View source ↗

Summary

Phase 2 asthma trial update focused on once-daily and bronchodilator dosing. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: COMPLETED